Hematology News

Claire E. Dearden, MD, Consultant Hematologist, Head of CLL Clinic, Royal Marsden Hospital, London, UK, highlights the pharmacotherapeutic strategies for the management of B- and T-cell PLL, noting the clinical outcomes associated with the diseases, and briefly touches on the future of PLL therapy.

Elan Corp. PLC plans to pay about $338 million for a privately held, Austrian drug developer and at least $110 million for stakes in two other companies as the Irish drugmaker continues to refocus after unloading its main revenue source, an ownership stake in the multiple sclerosis drug Tysabri.

Two-year-old Heaven Mesa of Victorville, was all smiles as Walter's Children's Charity Classic founders, Steve and Cathy Kienle, presented Loma Linda University Children's Hospital with a check for $172,500 on Tuesday, April 23, 2013.

's Federal Joint Committee has issued its final benefit assessment report for PIXUVRI , which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma who have failed two or three prior lines of therapy.

Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found.

Researchers from University Hospitals Case Medical Center's Seidman Cancer Center in Cleveland, OH, will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.

We used long-distance inverse-polymerase chain reaction to characterize the chromosomal rearrangement of individual acute leukemia patients.

From the Divisions of Nephrology and Hypertension, Department of Internal Medicine , Division of Biomedical Statistics and Informatics , Division of Hematology, Department of Internal Medicine , Department of Obstetrics and Gynecology , and Department of Laboratory Medicine and Pathology , Mayo Clinic, Rochester, MN.

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope .

Main Category: Infectious Diseases / Bacteria / Viruses Also Included In: Blood / Hematology ; Public Health Article Date: 15 May 2013 - 1:00 PDT New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units ... (more)

CLEVELAND: Researchers from University Hospitals Case Medical Center's Seidman Cancer Center will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials.

The U.S. Food and Drug Administration announced Wednesday that it has approved a drug to help men with advanced prostate cancer whose disease has spread to the bones.

A 3D model of the planned 2.2million chemotherapy and day treatment unit at North Devon District Hospital was unveiled on Monday 13 May.

Cincinnati Children's Hospital Medical Center has formed a partnership with one of the largest pediatric hospitals in China with plans to collaborate on cancer and blood diseases.

Main Category: Pharmacy / Pharmacist Also Included In: Public Health ; Blood / Hematology ; Medicare / Medicaid / SCHIP Article Date: 14 May 2013 - 0:00 PDT As hospitals look for ways to improve patient satisfaction and boost their Medicare reimbursement, a Henry Ford Hospital study found that an inpatient pharmacist-directed anticoagulation ... (more)

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope .

Atlas Pipeline Partners, L.P. engages in the gathering and processing segments of the midstream natural gas industry.

Main Category: Cardiovascular / Cardiology Also Included In: Medical Devices / Diagnostics ; Blood / Hematology Article Date: 13 May 2013 - 0:00 PDT A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas ... (more)

Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment ... (more)

From the Public Health Genomics Unit, National Institute for Health and Welfare, Biomedicum, Helsinki, Finland ; Wihuri Research Institute, Biomedicum, Helsinki, Finland ; Perelman School of Medicine at the University of Pennsylvania, PA, ; Division of Nutritional Science, Cornell University, Ithaca, NY ; and Department of Internal Medicine and ... (more)